Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2022.0480
Abstract: This randomized clinical trial investigates the effect of 15-mg edoxaban in patients aged 80 years and older who are not candidates for standard-dose oral anticoagulants owing to bleeding risk. read more here.
Keywords: edoxaban clinical; clinical outcomes; effect; effect edoxaban ... See more keywords
Comparing the Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in the Elderly Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study.
Sign Up to like & getrecommendations! Published in 2019 at "Chest"
DOI: 10.1016/j.chest.2019.11.025
Abstract: BACKGROUND Stroke prevention in elderly patients with atrial fibrillation (AF) can be challenging, requiring a balance between thromboembolism prevention and serious bleeding. Comparisons of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in the elderly,… read more here.
Keywords: atrial fibrillation; non vitamin; age; age strata ... See more keywords
Clinical Features and Outcomes of Pediatric and Adult Patients Hospitalized for Coronavirus Disease 2019: A Comparison Across Age Strata
Sign Up to like & getrecommendations! Published in 2024 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofae443
Abstract: Abstract Background Coronavirus disease 2019 (COVID-19) continues to cause hospitalizations and severe disease in children and adults. Methods This study compared the risk factors, symptoms, and outcomes of children and adults hospitalized for COVID-19 from… read more here.
Keywords: disease 2019; coronavirus disease; disease; age strata ... See more keywords